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Clinical PerspectiveWhat Is New?Data obtained in a general population are less prone to bias than studies performed in hypertensive populations.Our literature search did not identify any longitudinal study comparing associations of multiple indexes of diastolic left ventricular function with conventional versus daytime ambulatory blood pressure and linking blood pressure categories at baseline with diastolic left ventricular function at follow‐up.What Are the Clinical Implications?The take‐home message of our current study is that multiple measurements of blood pressure outside the medical environment are superior to fewer measurements by observers to screen for diastolic left ventricular dysfunction and that ambulatory monitoring, as already proposed more than a decade ago by Thomas Pickering and as reiterated in contemporary guidelines, is the state‐of‐the‐art technique for assessing blood pressure in clinical practice and research.

 {#jah32924-sec-0008}

In view of the epidemiological transition, heart failure (HF) is a major public health problem.[1](#jah32924-bib-0001){ref-type="ref"} Diastolic HF, also referred to as HF with preserved ejection fraction, accounts for 50% of cases.[2](#jah32924-bib-0002){ref-type="ref"} Mortality of diastolic HF is 30% within 1 year of the first hospital admission.[3](#jah32924-bib-0003){ref-type="ref"} Subclinical diastolic left ventricular (LV) dysfunction has a prevalence of 25% in the general population,[4](#jah32924-bib-0004){ref-type="ref"}, [5](#jah32924-bib-0005){ref-type="ref"} predisposes to further deterioration of LV function,[6](#jah32924-bib-0006){ref-type="ref"} and finally evolves to overt HF.[2](#jah32924-bib-0002){ref-type="ref"} Raised blood pressure is the major risk factor associated cross‐sectionally[4](#jah32924-bib-0004){ref-type="ref"}, [5](#jah32924-bib-0005){ref-type="ref"}, [7](#jah32924-bib-0007){ref-type="ref"} and prospectively[6](#jah32924-bib-0006){ref-type="ref"}, [8](#jah32924-bib-0008){ref-type="ref"}, [9](#jah32924-bib-0009){ref-type="ref"}, [10](#jah32924-bib-0010){ref-type="ref"} with diastolic LV dysfunction in the general population. Most studies making this point relied on conventional office blood pressure. However, all current hypertension guidelines[11](#jah32924-bib-0011){ref-type="ref"}, [12](#jah32924-bib-0012){ref-type="ref"}, [13](#jah32924-bib-0013){ref-type="ref"}, [14](#jah32924-bib-0014){ref-type="ref"} endorse the use of ambulatory monitoring as the state‐of‐the‐art method for monitoring blood pressure, because the greater number of readings obtained over the whole day outside the medical environment enhance risk stratification.

The single prospective population study of diastolic LV dysfunction[10](#jah32924-bib-0010){ref-type="ref"} that applied ambulatory monitoring covered a narrow age range (40--59 years), only reported on the echocardiographically assessed LV filling pressure, did not compare the predictive value of ambulatory versus office blood pressure, and did not report on diastolic LV function in truly normotensive people versus patients with white‐coat, masked, or sustained hypertension. To address these knowledge gaps, we analyzed the database of the FLEMENGHO (Flemish Study on Environment, Genes and Health Outcomes).[4](#jah32924-bib-0004){ref-type="ref"}, [6](#jah32924-bib-0006){ref-type="ref"}, [15](#jah32924-bib-0015){ref-type="ref"} We assessed to what extent office compared with ambulatory blood pressure predicted over a 10‐year span multiple echocardiographic indexes capturing diastolic LV function, first in all people combined, and next in participants categorized according to the guideline‐endorsed operational thresholds of their baseline office and ambulatory blood pressure.

Methods {#jah32924-sec-0009}
=======

Study Population {#jah32924-sec-0010}
----------------

FLEMENGHO complies with the Helsinki declaration for research in human subjects.[16](#jah32924-bib-0016){ref-type="ref"} The Ethics Committee of the University of Leuven approved the study. At each contact, participants renewed informed written consent. The data, analytic methods, and study materials will not be made available to other researchers for purposes of reproducing the results or replicating the procedure, because informed consent did not cover this option. Recruitment started in 1985 and continued until 2004.[4](#jah32924-bib-0004){ref-type="ref"}, [6](#jah32924-bib-0006){ref-type="ref"}, [15](#jah32924-bib-0015){ref-type="ref"} The initial participation rate was 78.0%. Of 3343 participants enrolled from 1985 until 2004, 2904 had their daytime ambulatory blood pressure measured (1989--2008) and afterwards 828 underwent echocardiography (2005--2010). The participation rate for ambulatory blood pressure monitoring and echocardiography amounted to 94.7% and 76.0%, respectively. In the context of this article, baseline and follow‐up, respectively, refer to the timing of blood pressure monitoring and echocardiography (Figure [1](#jah32924-fig-0001){ref-type="fig"}).

![Flowchart summarizing inclusion of participants in the study. ABPM refers to ambulatory blood pressure (BP) measurement.](JAH3-7-e007868-g001){#jah32924-fig-0001}

We excluded participants from analysis if the daytime ambulatory blood pressure was the mean of \<10 readings (n=35), if diastolic LV function could not be reliably graded, because of image quality (n=16), atrial fibrillation (n=8), or paced heart rhythm (n=3). This left 790 participants with both conventional and ambulatory blood pressure measured and with gradable echocardiographic images. Finally, we excluded 10 participants because their blood pressure levels were \>3 SDs higher than the population mean. Thus, the number of participants statistically analyzed totaled 780.

Clinical Measurements {#jah32924-sec-0011}
---------------------

Nurses measured blood pressure at baseline[17](#jah32924-bib-0017){ref-type="ref"} and follow‐up by auscultation of the Korotkoff sounds. After the participants had rested for 5 minutes in the sitting position, the observers obtained 5 consecutive blood pressure readings (phase V diastolic pressure) to the nearest 2 mm Hg, using mercury sphygmomanometers. Standard cuffs had a 12×24‐cm inflatable portion, but if upper arm girth exceeded 31 cm, larger cuffs with 15×35‐cm bladders were used. For analysis, the 5 blood pressure readings obtained at baseline or at follow‐up were averaged. From baseline to follow‐up, we implemented a stringent quality control program described elsewhere.[18](#jah32924-bib-0018){ref-type="ref"}, [19](#jah32924-bib-0019){ref-type="ref"} Hypertension on conventional blood pressure measurement was a blood pressure ≥140 mm Hg systolic or 90 mm Hg diastolic.

At baseline, participants wore validated[20](#jah32924-bib-0020){ref-type="ref"} SpaceLabs 90204 or 90207 portable monitors (Spacelabs Healthcare, Snoqualmie, WA) to record their daytime ambulatory blood pressure from 8 [am]{.smallcaps} until 10 [pm]{.smallcaps} at 20‐minute intervals. As an alternative, they could also opt having their blood pressure monitored over 24 hours, but for the current study only the daytime part of these recordings was analyzed. The recordings were sparsely edited, removing only readings labeled with an error code or with lower systolic than diastolic blood pressure level. For continuous analyses,[21](#jah32924-bib-0021){ref-type="ref"} we computed the daytime blood pressure as the within‐individual mean of the readings between 10 [am]{.smallcaps} and 8 [pm]{.smallcaps} weighted for the interval between readings. This short definition of daytime eliminates the transition periods in the morning and evening during which blood pressure changes rapidly in most people and approximates within 1 to 2 mm Hg to the wakeful blood pressure recorded by the diary method.[22](#jah32924-bib-0022){ref-type="ref"} In categorical analyses, ambulatory hypertension was a daytime blood pressure of 135 mm Hg systolic or 85 mm Hg diastolic or higher.[13](#jah32924-bib-0013){ref-type="ref"} Normotension and sustained hypertension were a consistently normal or elevated blood pressure on conventional and ambulatory measurement. White‐coat hypertension was a raised conventional blood pressure in the presence of a normal daytime blood pressure. Masked hypertension was an elevated ambulatory blood pressure with normal conventional blood pressure. Participants were categorized based on blood pressure levels only, irrespective of treatment with antihypertensive drugs.[23](#jah32924-bib-0023){ref-type="ref"}

Echocardiography {#jah32924-sec-0012}
----------------

The acquisition and off‐line analysis of the echocardiographic images were done according to current guidelines.[24](#jah32924-bib-0024){ref-type="ref"}, [25](#jah32924-bib-0025){ref-type="ref"} Previous publications describe the procedures applied for acquisition and the off‐line analysis of the echocardiographic measurements in detail.[4](#jah32924-bib-0004){ref-type="ref"}, [6](#jah32924-bib-0006){ref-type="ref"} In short, digitally stored echocardiographic images, obtained with a Vivid7 Pro (GE Vingmed, Horten, Norway) interfaced with a 2.5‐ to 3.5‐MHz phased‐array probe, were averaged over 3 heart cycles. End‐diastolic LV dimensions were used to calculate LV mass by an anatomically validated formula according to the recommendations of the American Society of Echocardiography.[24](#jah32924-bib-0024){ref-type="ref"}, [25](#jah32924-bib-0025){ref-type="ref"} Left atrial (LA) volume was calculated using the prolate‐elipsoid method. Diastolic LV function was assessed by EchoPac software, version 4.0.4 (GE Vingmed). We determined early (E) and late (A) diastolic peak velocities of the transmitral blood flow from the pulsed Doppler signal and early (e′) and late (a′) peak velocities of the mitral annular movement by tissue Doppler imaging. The tissue Doppler imaging measurements were averaged over 4 acquisition sites (septal, lateral, inferior, and posterior). The intraobserver reproducibility of the single observer in the study (T.K.), defined as the 2‐SD interval about the mean of the relative differences between duplicate readings, across the 4 tissue Doppler imaging sampling sites, ranged from 4.5% to 5.3% for e′ and from 4.0% to 4.5% for a′.[6](#jah32924-bib-0006){ref-type="ref"}

Other Measurements {#jah32924-sec-0013}
------------------

The study nurses counted heart rate for 1 minute and measured the participants' anthropometric characteristics. Body mass index was weight in kilograms divided by height in meters squared. They also administered a standardized questionnaire inquiring into each participant\'s medical history, smoking and drinking habits, and intake of medications. Consumption of alcohol was a daily intake of at least 5 g of ethanol per day.[26](#jah32924-bib-0026){ref-type="ref"} Plasma glucose and total serum cholesterol were measured using automated methods in a single certified laboratory. Diabetes mellitus was a fasting or random glucose level exceeding 126 or 200 mg/dL (7.0 or 11.1 mmol/L), or use of antidiabetic agents.[27](#jah32924-bib-0027){ref-type="ref"}

Statistical Analysis {#jah32924-sec-0014}
--------------------

For database management and statistical analysis, we used SAS software, version 9.4. We compared means and proportions between groups by ANOVA and the χ^2^ statistic, respectively. We applied a paired *t* test and McNemar test to assess changes over time in means and proportions. Statistical significance was a 2‐sided significance level of 0.05.

In exploratory analyses, we plotted the sex‐ and age‐adjusted indexes of diastolic LV function by fifths of the distributions of conventional and daytime blood pressure at baseline. As described before,[4](#jah32924-bib-0004){ref-type="ref"}, [6](#jah32924-bib-0006){ref-type="ref"} covariables in the multivariable‐adjusted analyses included sex, the baseline characteristics age, body mass index, heart rate, serum total cholesterol, plasma glucose, γ‐glutamyltransferase (index of alcohol intake)[28](#jah32924-bib-0028){ref-type="ref"} and smoking, use of lipid‐lowering treatment at follow‐up, 3 indicator variables coding for starting, stopping, or continuing antihypertensive drug treatment from baseline to follow‐up, and duration of follow‐up. We computed the variance inflation factor from regression models that included both conventional and daytime blood pressure.[29](#jah32924-bib-0029){ref-type="ref"} The final multivariable‐adjusted estimates were derived from mixed models that accounted for family clusters modeled as a random effect with the other covariables entered as fixed effects. In sensitivity analyses, we modeled diastolic LV function indexes in relation to the daytime blood pressure at baseline and the conventional blood pressure at follow‐up.

Results {#jah32924-sec-0015}
=======

Characteristics of Participants {#jah32924-sec-0016}
-------------------------------

All 780 participants were white Europeans, of whom 403 (51.7%) were women. The study population consisted of 116 singletons and 664 related subjects, belonging to 131 one‐generation families and to 61 complex pedigrees. Table [1](#jah32924-tbl-0001){ref-type="table-wrap"} shows the clinical characteristics at baseline and follow‐up. In all participants (Table [1](#jah32924-tbl-0001){ref-type="table-wrap"}), mean baseline values were 40.2 years for age, 121.8/75.4 and 123.0/76.0 mm Hg for systolic/diastolic blood pressure on conventional and daytime ambulatory measurement, and 25.0 kg/m^2^ for body mass index. Median follow‐up was 9.6 years (5th--95th percentile interval, 5.5--16.1 years). From baseline to follow‐up (Table [1](#jah32924-tbl-0001){ref-type="table-wrap"}), the prevalence of smoking decreased from 26.5% to 21.2%, whereas the proportion of people drinking 5 g alcohol or more daily increased from 23.6% to 40.6%. Body mass index, the prevalence of overweight and obesity, conventional blood pressure, and treatment rates for hypertension and dyslipidemia increased from baseline to follow‐up. Serum total cholesterol and plasma glucose decreased over time.

###### 

Characteristics of 780 Participants at Baseline and Follow‐Up

  Characteristic                           Baseline            Follow‐Up           *P* Value
  ---------------------------------------- ------------------- ------------------- -----------
  Number with characteristics (%)                                                  
  Current smoker                           207 (26.5)          165 (21.2)          \<0.001
  Drinking alcohol ≥5 g/d                  184 (23.6)          317 (40.6)          \<0.001
  Overweight                               296 (38.0)          344 (44.1)          \<0.001
  Obesity                                  77 (9.9)            137 (17.6)          \<0.001
  Diabetes mellitus                        8 (1.0)             29 (3.7)            \<0.001
  Conventional hypertension                143 (18.3)          312 (40.0)          \<0.001
  Daytime hypertension                     122 (15.6)          ···                 
  On antihypertensive drugs                61 (7.8)            185 (23.7)          \<0.001
  Lipid‐lowering treatment                 16 (2.0)            112 (14.4)          \<0.001
  Mean of characteristic (±SD)                                                     
  Age, y                                   40.2±14.4           50.6±15.4           \<0.001
  Body mass index, kg/m^2^                 25.0±4.1            26.4±4.2            \<0.001
  Conventional blood pressure                                                      
  Systolic, mm Hg                          121.8±13.8          128.7±17.1          \<0.001
  Diastolic, mm Hg                         75.4±10.2           79.5±9.4            \<0.001
  Daytime blood pressure                                                           
  Systolic, mm Hg                          123.0±9.9           ···                 
  Diastolic, mm Hg                         76.0±7.8            ···                 
  Heart rate, bpm                          69.1±10.0           63.5±9.5            \<0.001
  Total cholesterol, mmol/L                5.33±1.11           5.24±0.96           0.013
  Plasma glucose, mmol/L                   4.98±1.28           4.94±0.81           0.38
  Geometric mean (IQR) of characteristic                                           
  γ‐Glutamyltransferase (U/L)              21.4 (12.9--31.6)   22.9 (15.1--32.4)   \<0.001

Body mass index was body weight in kilogram divided by height in meters squared. Overweight and obesity refer to a body mass index of 25 to 29.9 and ≥30 kg/m^2^, respectively. Conventional hypertension was a blood pressure of ≥140 mm Hg systolic or ≥90 mm Hg diastolic. Daytime hypertension was a blood pressure of ≥135 mm Hg systolic or ≥85 mm Hg diastolic. *P* values indicate the significance of the difference between baseline and follow‐up. IQR indicates interquartile range.

Associations With Blood Pressure {#jah32924-sec-0017}
--------------------------------

The median number of readings averaged to estimate the daytime ambulatory blood pressure was 32 (5th--95th percentile interval, 20--40; range, 11--43). Mean values (±SD) of the echocardiographic measurements at follow‐up were the following: 22.8±6.30 mL/m^2^ and 91.3±21.4 g/m^2^ for the LA volume and LV mass indexes; 75.4±16.0 cm/s, 64.5±16.7 cm/s, and 1.26±0.48 for transmitral E, A, and E/A; 11.5±3.6 cm/s, 10.1±2.1 cm/s, and 1.26±0.64 for the tissue Doppler imaging indexes e′, a′, and e′/a′; and 6.98±1.91 for E/e′. In exploratory analyses, only adjusted for sex and age (Figure [2](#jah32924-fig-0002){ref-type="fig"}), the LA volume index and E/e′ increased (*P*≤0.007) and e′ decreased (*P*=0.001) with higher daytime systolic blood pressure, whereas the corresponding associations were directionally similar for systolic blood pressure on conventional measurement (*P*≤0.002), but not significant for the LA volume index (*P*=0.12).

![Sex‐ and age‐adjusted left atrial volume index (A), e′ (B), and E/e′ (C) at follow‐up by quintiles of the distribution of baseline systolic blood pressure on conventional (open circles) or daytime ambulatory (closed dots) blood pressure measurement. Vertical bars denote the SE. *P* values are for linear trend.](JAH3-7-e007868-g002){#jah32924-fig-0002}

In multivariable‐adjusted mixed models that accounted for family clusters (Table [2](#jah32924-tbl-0002){ref-type="table-wrap"}), the LV mass and LA volume indexes increased with higher systolic and diastolic daytime pressure (*P*≤0.004), but not with higher conventional pressure (*P*≥0.14). The association sizes per 10/5‐mm Hg increment in systolic/diastolic daytime blood pressure were 2.20/1.26 g/m^2^ and 0.62/0.31 mL/m^2^. The e′ peak velocity decreased with higher conventional (−0.16 cm/s; *P*\<0.001) and daytime (−0.24 cm/s; *P*\<0.001) diastolic blood pressure. E/e′ increased with higher conventional (+0.15; *P*=0.001) and daytime (+0.23; *P*\<0.001) systolic blood pressure.

###### 

Echocardiographic Indexes at Follow‐Up in Relation to Baseline Blood Pressure

  Model Echocardiographic Index   Systolic Blood Pressure                                    Diastolic Blood Pressure                                                                                                      
  ------------------------------- ---------------------------------------------------------- ----------------------------------------------------------- ----------------------------------------------------------------- ---------------------------------------------------------------
  Single blood pressure                                                                                                                                                                                                    
  LV mass index, g/m^2^           0.82 (−0.26 to 1.90)                                       2.20 (0.80--3.60)[†](#jah32924-note-0003){ref-type="fn"}    −0.01 (−0.72 to 0.69)                                             1.26 (0.39--2.13)[†](#jah32924-note-0003){ref-type="fn"}
  LA volume index, mL/m^2^        0.18 (−0.14 to 0.51)                                       0.62 (0.20--1.04)[†](#jah32924-note-0003){ref-type="fn"}    −0.06 (−0.27 to 0.16)                                             0.31 (0.05--0.57)[\*](#jah32924-note-0003){ref-type="fn"}
  e′ peak, cm/s                   −0.10 (−0.23 to 0.02)                                      −0.15 (−0.31 to 0.009)                                      −0.16 (−0.24 to −0.08)[‡](#jah32924-note-0003){ref-type="fn"}     −0.24 (−0.34 to −0.14)[‡](#jah32924-note-0003){ref-type="fn"}
  E/e′ ratio                      0.15 (0.06--0.24)[†](#jah32924-note-0003){ref-type="fn"}   0.23 (0.11--0.34)[‡](#jah32924-note-0003){ref-type="fn"}    −0.004 (−0.06 to 0.06)                                            0.07 (0.0004--0.15)[\*](#jah32924-note-0003){ref-type="fn"}
  Twin blood pressure                                                                                                                                                                                                      
  LV mass index, g/m^2^           0.01 (−1.21 to 1.24)                                       2.20 (0.60--3.79)[†](#jah32924-note-0003){ref-type="fn"}    −0.52 (−1.29 to 0.24)                                             1.53 (0.58--2.48)[†](#jah32924-note-0003){ref-type="fn"}
  LA volume index, mL/m^2^        −0.05 (−0.42 to 0.32)                                      0.65 (0.17--1.12)[†](#jah32924-note-0003){ref-type="fn"}    −0.19 (−0.42 to 0.05)                                             0.40 (0.12--0.69)[†](#jah32924-note-0003){ref-type="fn"}
  e′ peak, cm/s                   −0.06 (−0.02 to 0.08)                                      −0.11 (−0.29 to 0.07)                                       −0.09 (−0.18 to −0.008)[\*](#jah32924-note-0003){ref-type="fn"}   −0.19 (−0.30 to −0.09)[‡](#jah32924-note-0003){ref-type="fn"}
  E/e′ ratio                      0.09 (−0.01 to 0.20)                                       0.17 (0.04--0.30)[\*](#jah32924-note-0003){ref-type="fn"}   −0.03 (−0.10 to 0.03)                                             0.09 (0.01--0.17)[\*](#jah32924-note-0003){ref-type="fn"}

Association sizes (95% confidence interval) express the differences in the echocardiographic indexes associated with a 10‐mm Hg higher baseline systolic blood pressure or a 5‐mm Hg higher diastolic blood pressure. All models account for clustering within families and were adjusted for sex, the baseline characteristics age, body mass index, heart rate, serum total cholesterol, plasma glucose, γ‐glutamyltransferase (index of alcohol intake) and smoking, use of lipid‐lowering treatment at follow‐up, 3 indicator variables coding for starting, stopping, or continuing antihypertensive drug treatment from baseline to follow‐up, and duration of follow‐up. Single blood pressure models include the conventional or daytime blood pressure and twin models both. LV mass index was available in 750 participants, LA volume index in 763 and e′ and E/e′ in 780. E indicates early diastolic peak velocities; e′, early peak velocities of mitral annular movement; LA, left atrial; LV, left ventricular.

Significance of the associations: \**P*≤0.05; ^†^ *P*≤0.01; and ^‡^ *P*≤0.001.

In regression models that related the echocardiographic indexes to both conventional and daytime ambulatory blood pressure and included the fixed‐effect covariables, variance inflation factor was consistently lower than 2.0. In mixed models that included both blood pressure components, findings were confirmatory (Table [2](#jah32924-tbl-0002){ref-type="table-wrap"}). LV mass and LA volume indexes and E/e′ increased with higher systolic and diastolic daytime pressure (*P*≤0.028), but not with higher conventional pressure (*P*≥0.086). The association sizes per 10/5‐mm Hg increment in systolic/diastolic daytime blood pressure were 2.20/1.53 g/m^2^, 0.65/0.40 mL/m^2^, and 0.17/0.09. The e′ peak velocity decreased with higher conventional (−0.09 cm/s; *P*=0.032) and daytime (−0.19 cm/s; *P*\<0.001) diastolic blood pressure. In multivariable‐adjusted analyses additionally accounting for baseline conventional pulse pressure, a 10‐mm Hg higher daytime ambulatory pulse pressure was associated with a 0.20 greater E/e′ ratio (*P*=0.044).

Last, we replaced the conventional blood pressure measured at baseline by the office blood pressure measured concurrently with echocardiography (Table [3](#jah32924-tbl-0003){ref-type="table-wrap"}). Variance inflation factor for all of these models was lower than 1.6. LV mass and LA volume indexes and E/e′ increased with higher systolic and diastolic daytime pressure (*P*≤0.036). The association sizes per 10/5‐mm Hg increment in systolic/diastolic daytime blood pressure were 1.60/0.96 g/m^2^, 0.45/0.38 mL/m^2^, and 0.15/0.08. LV mass and LA volume indexes and E/e′ increased with higher conventional systolic pressure (*P*≤0.002). The association sizes per 10‐mm Hg increment in systolic conventional blood pressure were 1.44 g/m^2^, 0.53 mL/m^2^, and 0.19. The e′ peak velocity decreased with higher conventional (−0.20 cm/s; *P*\<0.001) and daytime (−0.17 cm/s; *P*\<0.001) diastolic blood pressure (Table [3](#jah32924-tbl-0003){ref-type="table-wrap"}).

###### 

Echocardiographic Indexes at Follow‐Up in Relation to Baseline Daytime and Follow‐Up Conventional Blood Pressure

  Model Echocardiographic Index   Systolic Blood Pressure                                    Diastolic Blood Pressure                                                                                                    
  ------------------------------- ---------------------------------------------------------- ----------------------------------------------------------- --------------------------------------------------------------- ---------------------------------------------------------------
  LV mass index, g/m^2^           1.44 (0.54--2.33)[†](#jah32924-note-0005){ref-type="fn"}   1.60 (0.17--3.04)[\*](#jah32924-note-0005){ref-type="fn"}   0.55 (−0.24 to 1.33)                                            0.96 (0.06--1.86)[\*](#jah32924-note-0005){ref-type="fn"}
  LA volume index, mL/m^2^        0.53 (0.26--0.79)[‡](#jah32924-note-0005){ref-type="fn"}   0.45 (0.03--0.88)[\*](#jah32924-note-0005){ref-type="fn"}   −0.17 (−0.41 to 0.06)                                           0.38 (0.12--0.65)[†](#jah32924-note-0005){ref-type="fn"}
  e′ peak, cm/s                   −0.04 (−0.14 to 0.05)                                      −0.11 (−0.26 to 0.04)                                       −0.20 (−0.28 to −0.12)[‡](#jah32924-note-0005){ref-type="fn"}   −0.17 (−0.27 to −0.08)[‡](#jah32924-note-0005){ref-type="fn"}
  E/e′ ratio                      0.19 (0.12--0.26)[‡](#jah32924-note-0005){ref-type="fn"}   0.15 (0.03--0.26)[\*](#jah32924-note-0005){ref-type="fn"}   0.01 (−0.05 to 0.08)                                            0.08 (0.01--0.16)[\*](#jah32924-note-0005){ref-type="fn"}

Association sizes (95% confidence interval) express the differences in the echocardiographic indexes associated with a 10‐mm Hg higher systolic blood pressure or a 5‐mm Hg higher diastolic blood pressure. All models included both blood pressure components, account for clustering within families, and were adjusted for sex, the follow‐up characteristics age, body mass index, heart rate, serum total cholesterol, plasma glucose, γ‐glutamyltransferase (index of alcohol intake) and smoking, and use of lipid‐lowering treatment, 3 indicator variables coding for starting, stopping, or continuing antihypertensive drug treatment from baseline to follow‐up, and duration of follow‐up. LV mass index was available in 750 participants, LA volume index in 763, and e′ and E/e′ in 780. E indicates early diastolic peak velocities; e′, early peak velocities of mitral annular movement; LA, left atrial; LV, left ventricular.

Significance of the associations: \**P*≤0.05; ^†^ *P*≤0.01; and ^‡^ *P*≤0.001.

Associations With Blood Pressure Category {#jah32924-sec-0018}
-----------------------------------------

Of the 780 participants, at baseline, 604 (77.4%) were truly normotensive based on their conventional and daytime blood pressure and 54 (6.9%), 74 (9.5%), and 48 (6.2%) had white‐coat, masked, or sustained hypertension. Among 54 white‐coat hypertensive patients, the conventional blood pressure thresholds were met by 28 participants (51.8%) for systolic pressure, by 17 (31.5%) for diastolic pressure, and by 9 (16.7%) for systolic and diastolic blood pressure. Among the 74 participants with masked hypertension, 9 (12.2%) satisfied the daytime threshold for systolic pressure, 13 (17.6%) the diastolic threshold, and 52 (70.3%) both.

Table [4](#jah32924-tbl-0004){ref-type="table-wrap"} shows the echocardiographic traits by cross‐classification based on the baseline conventional and daytime blood pressure. Compared with participants with true normotension, patients with ambulatory hypertension at baseline (15.6%) had larger LV mass index (102.7 versus 89.3 g/m^2^; *P*\<0.001), LA volume index (25.4 versus 22.3 mL/m^2^; *P*\<0.001) and E/e′ ratio (7.64 versus 6.86; *P*\<0.001), and smaller e′ (9.6 versus 11.8 cm/s; *P*\<0.001) at follow‐up. Sustained or masked hypertension at baseline compared with normotension or white‐coat hypertension (Figure [3](#jah32924-fig-0003){ref-type="fig"}) were associated with greater LA volume index (24.0 versus 22.6 mL/m^2^; *P*=0.006) and E/e′ (7.35 versus 6.91; *P*=0.005) and lower e′ (10.7 versus 11.6 cm/s; *P*\<0.001) with no differences between normotension and white‐coat hypertension (*P*≥0.16) or between masked and sustained hypertension (*P*≥0.092). A sensitivity analysis from which we excluded 61 participants on antihypertensive drug treatment at baseline produced confirmatory results (Table [4](#jah32924-tbl-0004){ref-type="table-wrap"}).

###### 

Echocardiographic Indexes by Hypertension Category at Baseline

  Echocardiographic Indexes    Normotension   White‐Coat Hypertension   Masked Hypertension   Sustained Hypertension   *P* ~NT~   *P* ~WT~   *P* ~MT~
  ---------------------------- -------------- ------------------------- --------------------- ------------------------ ---------- ---------- ----------
  All (n=780)                  604            54                        74                    48                                             
  LV mass index, g/m^2^        90.1±0.70      90.3±2.4                  97.2±2.0              99.3±2.7                 0.002      0.011      0.52
  Ejection fraction, %         68.2±0.31      70.6±1.0                  70.2±0.88             69.7±1.2                 0.23       0.58       0.74
  LA volume index, mL/m^2^     22.6±0.22      21.7±0.73                 23.4±0.61             25.1±0.82                0.004      0.001      0.092
  e′ peak, cm/s                11.6±0.08      11.4±0.27                 10.5±0.23             11.0±0.30                0.033      0.23       0.20
  E/e′ ratio                   6.89±0.06      7.13±0.21                 7.34±0.17             7.39±0.23                0.038      0.39       0.86
  Baseline Untreated (n=719)   569            42                        69                    39                                             
  LV mass index, g/m^2^        89.2±0.70      93.0±2.6                  96.2±2.0              97.3±3.0                 0.034      0.29       0.98
  Ejection fraction, %         68.1±0.32      71.3±1.2                  70.1±0.91             69.1±1.3                 0.50       0.20       0.53
  LA volume index, mL/m^2^     22.3±0.23      21.9±0.84                 23.3±0.65             25.1±0.94                0.008      0.004      0.14
  e′ peak, cm/s                11.9±0.08      11.5±0.31                 10.8±0.24             11.3±0.34                0.069      0.62       0.24
  E/e′ ratio                   6.79±0.06      7.04±0.22                 7.20±0.17             7.04±0.24                0.33       0.99       0.60

Values are mean±SE. All estimates account for clustering within families. Estimates were adjusted for sex, the baseline characteristics age, body mass index, heart rate, serum total cholesterol, plasma glucose, γ‐glutamyltransferase (index of alcohol intake) and smoking, for use of lipid‐lowering treatment at follow‐up, for 3 indicator variables coding for starting, stopping, or continuing antihypertensive drug treatment from baseline to follow‐up, and for duration of follow‐up. LV mass index (untreated at baseline) was available in 750 (694) participants, ejection fraction in 708 (655), LA volume index in 763 (703), and e′ and E/e′ in 780 (719). E indicates early diastolic peak velocities; e′, early peak velocities of mitral annular movement; LA, left atrial; LV, left ventricular; *P* ~MT~, the significance of the difference between masked hypertension and sustained hypertension; *P* ~NT~ *,* the significance of the difference between normotension and sustained hypertension; *P* ~WT~ *,* the significance of the difference between white‐coat hypertension and sustained hypertension.

![Multivariable‐adjusted means of left atrial volume index (A), e′ (B), and E/e′ (C) at follow‐up by hypertension category at baseline. NT,WHT,MHT, and SHT indicate true normotension and white‐coat, masked, and sustained hypertension, respectively. Estimates given with SE account for clustering within families and were adjusted for sex, the baseline characteristics age, body mass index, heart rate, serum total cholesterol, plasma glucose, γ‐glutamyltransferase (index of alcohol intake) and smoking, for use of lipid‐lowering treatment at follow‐up, for 3 indicator variables coding for starting, stopping, or continuing antihypertensive drug treatment from baseline to follow‐up, and for duration of follow‐up. Left atrial volume index was available in 763 participants and e′ and E/e′ in 780. *P* values are for the between‐group comparisons. LAVI indicates left atrial volume index.](JAH3-7-e007868-g003){#jah32924-fig-0003}

Discussion {#jah32924-sec-0019}
==========

The key finding of our study was that ambulatory blood pressure is a long‐term predictor of diastolic LV function statistically outperforming distant but not concurrent conventional blood pressure, and that masked and sustained hypertension are equal predictors of worse diastolic LV function over a 10‐year horizon. Concurrent conventional blood pressure might directly influence the LV loading conditions and LV filling. This might explain why conventional concurrent compared with distant baseline blood pressure performed better in the associations with the indexes of LV diastolic function. The clinical implication is that ambulatory blood pressure monitoring is a prerequisite for the long‐term risk stratification for impaired diastolic LV function in relation to blood pressure. Only out‐of‐the office blood pressure monitoring allows differentiation between true normotension and risk‐carrying masked hypertension[23](#jah32924-bib-0023){ref-type="ref"} among individuals with normal office blood pressure or between low‐risk white‐coat hypertension[30](#jah32924-bib-0030){ref-type="ref"} and sustained hypertension.

To our surprise, a thorough literature search of the PubMed database, using as search terms "blood pressure" OR "ambulatory blood pressure" OR "hypertension" AND "heart" OR "left ventricular diastolic function" revealed only 1 other longitudinal population study relating E/e′ at follow‐up to the ambulatory blood pressure measured 20 years earlier.[10](#jah32924-bib-0010){ref-type="ref"} This Finnish study included 414 individuals enrolled in the OPERA (Oulu Project Elucidating Risk of Atherosclerosis) study.[10](#jah32924-bib-0010){ref-type="ref"} Age ranged from 40 to 59 years. E/e′ was the only echocardiographic index of diastolic LV function reported and analyzed as a categorical variable using a threshold of 15 to discriminate between normal (n=381) and impaired (n=33) diastolic LV performance. With adjustments applied for sex, age, stature, body mass index, prevalence of diabetes mellitus, office systolic and pulse pressure, N‐terminal pro‐atrial natriuretic peptide, and the use of antihypertensive therapy, there was no association between diastolic LV dysfunction and the 24‐hour, daytime or nighttime systolic or diastolic blood pressure. However, with additional adjustment for ambulatory diastolic blood pressure, diastolic LV dysfunction at follow‐up was associated with higher baseline pulse pressure on 24‐hour (53.4 versus 46.4 mm Hg; *P*=0.001), daytime (54.3 versus 47.0 mm Hg; *P*=0.016), and nighttime blood pressure measurements (51.2 versus 44.2 mm Hg; *P*=0.015).[10](#jah32924-bib-0010){ref-type="ref"} This Finnish study did not compare the predictive performance of the office and ambulatory blood pressure and, in view of the low number of cases and the complex adjustments for highly intercorrelated covariables, remains difficult to interpret.

The Finnish OPERA study[8](#jah32924-bib-0008){ref-type="ref"} and the United Kingdom Medical Research Council National Survey of Health and Development[9](#jah32924-bib-0009){ref-type="ref"} reported on the longitudinal associations between diastolic LV function and the conventional blood pressure. Using the same approach as in their article on ambulatory blood pressure,[10](#jah32924-bib-0010){ref-type="ref"} the OPERA investigators demonstrated that greater in‐office systolic blood pressure, shorter height, and lower estimated glomerular filtration rate in middle‐aged people were forerunners of diastolic dysfunction 20 years later.[8](#jah32924-bib-0008){ref-type="ref"} In 1653 singletons enrolled in the Medical Research Council National Survey of Health and Development birth cohort, investigators measured the participants' conventional blood pressure, using the Hawskley random‐zero sphygmomanometer or an oscillometric device at ages 36, 43, 53, and 60 to 64 years.[9](#jah32924-bib-0009){ref-type="ref"} At the last follow‐up visit, diastolic LV function was also assessed. Increased systolic blood pressure at 36, 43, and 53 years was predictive of increased E/e′ and increased LA volume index. These effects were only partially explained by systolic blood pressure at 60 to 64 years or increased LV mass. Antihypertensive drug treatment was also associated with poorer diastolic function after adjustment for systolic blood pressure at age 60 to 64 years. The authors concluded that faster rates of increase in systolic blood pressure in midlife were associated with poorer diastolic function.[9](#jah32924-bib-0009){ref-type="ref"}

In categorized analyses of baseline data, we demonstrated that sustained or masked hypertension compared with normotension or white‐coat hypertension was associated with greater LA volume index and E/e′ and lower e′ with no differences between normotension and white‐coat hypertension[30](#jah32924-bib-0030){ref-type="ref"} or between masked and sustained hypertension. Data obtained in a general population are less prone to bias than studies performed in hypertensive populations. Our literature search did not identify any longitudinal study linking blood pressure categories at baseline with diastolic LV function at follow‐up. In a cross‐sectional study of 52 111 Korean adults who had their office blood pressure measured oscillometrically and who were examined echocardiographically, the adjusted mean E/e′ ratio was 7.56 in normotensive people, 7.89 and 8.17 in prehypertensive and controlled hypertensive patients, and 8.28 and 8.54 in newly diagnosed and uncontrolled patients.[31](#jah32924-bib-0031){ref-type="ref"} The LV mass and LA volume indexes showed similar trends.[31](#jah32924-bib-0031){ref-type="ref"} The International Database on Ambulatory blood pressure monitoring in relation to Cardiovascular Outcome includes randomly enrolled population samples who had office and ambulatory blood pressure and cardiovascular risk factors measured at baseline with a longitudinal follow‐up of fatal and nonfatal cardiovascular outcomes.[23](#jah32924-bib-0023){ref-type="ref"} Using a daytime threshold of 135/85 mm Hg,[13](#jah32924-bib-0013){ref-type="ref"} the prevalence of normotension and white‐coat, masked, and sustained hypertension was 49.4%, 10.6%, 14.6%, and 25.4%, respectively.[23](#jah32924-bib-0023){ref-type="ref"} The multivariable‐adjusted risk associated with white‐coat hypertension did not differ from normotension, whereas masked hypertension conferred a risk not different from that of sustained hypertension.[23](#jah32924-bib-0023){ref-type="ref"} Our current study extends the International Database on Ambulatory blood pressure monitoring in relation to Cardiovascular Outcome findings to a trait reflecting intermediate target organ damage (ie, diastolic LV dysfunction).

The clinical implications of our current findings can be gauged against the prognosis associated with asymptomatic diastolic LV dysfunction, which in the general population has a prevalence of around 25%[4](#jah32924-bib-0004){ref-type="ref"}, [5](#jah32924-bib-0005){ref-type="ref"} and over time evolves to symptomatic LV dysfunction[6](#jah32924-bib-0006){ref-type="ref"} and heart failure[2](#jah32924-bib-0002){ref-type="ref"} and predicts the incidence of adverse health outcomes. Guideline‐driven echocardiographic criteria[24](#jah32924-bib-0024){ref-type="ref"}, [25](#jah32924-bib-0025){ref-type="ref"} to stage patients with advanced diastolic LV dysfunction leave a large proportion of people unclassified in population studies. As we reported previously,[32](#jah32924-bib-0032){ref-type="ref"} the threshold of 7 cm/s for e′ corresponds with the 10th percentile of the distribution in the current study population and the thresholds 14 for E/e′ and 34 mL/m^2^ for LAVI are equivalent to the 95th percentiles of their distribution. Among 793 Flemish followed up for 5 years, the multivariable‐adjusted hazard ratios per 1‐SD decrease (*P*=0.001) in e′ amounted to 2.50 and 3.66 for cardiovascular and cardiac complications, respectively.[33](#jah32924-bib-0033){ref-type="ref"} Furthermore, in 2042 participants enrolled in the Olmsted County Study[34](#jah32924-bib-0034){ref-type="ref"} and followed up for 3.5 years, mild (20.8%) and moderate‐to‐severe (7.3%) diastolic LV dysfunction at baseline predicted all‐cause mortality with hazard ratios of 8.3 and 10.2 (*P*\<0.001). In the Framingham Heart Study, remote blood pressure (average of all reading 11--20 years before current) and recent blood pressure (average of all reading 1--10 years before current) predicted the risk of cardiovascular disease incrementally over current blood pressure.[35](#jah32924-bib-0035){ref-type="ref"} This observation was consistent irrespective of sex and age.[35](#jah32924-bib-0035){ref-type="ref"} Explanations offered by the Framingham investigators were that antecedent blood pressure is a forerunner of cardiovascular target organ damage, which is on the path to hard cardiovascular complications, and that the relation between cardiovascular risk and blood pressure weakens over time by the initiation of antihypertensive drug treatment.[35](#jah32924-bib-0035){ref-type="ref"} What our current study adds is that ambulatory blood pressure is a long‐term predictor of diastolic LV function, statistically outperforming distant but not concurrent conventional blood pressure.

Our current study must be interpreted within the context of some potential limitations. First, in line with current practice,[13](#jah32924-bib-0013){ref-type="ref"} we used daytime not 24‐hour ambulatory or nighttime blood pressure to categorize our participants. Our study participants could opt to have their 24‐hour blood pressure monitored. However, in view of the discomfort caused by nighttime blood pressure readings, only 290 had whole‐day recordings. Participants opting for 24‐hour instead of daytime‐only monitoring had similar sex distribution and prevalence of smoking and plasma glucose (*P*≥0.36), but were on average 6.0 years older and therefore had a slightly but significantly (*P*≤0.038) higher body mass index, blood pressure, serum cholesterol, and plasma glucose. Previous studies demonstrated that using daytime or 24‐hour blood pressure yields similar proportions of patients with white‐coat and masked hypertension[36](#jah32924-bib-0036){ref-type="ref"} as well as similar estimates of cardiovascular risk.[37](#jah32924-bib-0037){ref-type="ref"} Second, the prevalence of white‐coat hypertension in our study was about two thirds less as compared with other studies of populations[23](#jah32924-bib-0023){ref-type="ref"}, [37](#jah32924-bib-0037){ref-type="ref"} and patients.[36](#jah32924-bib-0036){ref-type="ref"} However, our participants were repeatedly followed up by the same team of study nurses living in the catchment area of the study. Familiarization of participants with the study team is a likely explanation of the low prevalence of white‐coat hypertension and the 5.6‐beat/min decrease in heart rate from baseline to follow‐up.[38](#jah32924-bib-0038){ref-type="ref"} Finally, our study included only white Europeans. However, in the international multiethnic International Database on Ambulatory blood pressure monitoring in relation to Cardiovascular Outcome study, there were no differences in the risks associated with blood pressure among Europeans, Asians, and South Americans.[37](#jah32924-bib-0037){ref-type="ref"}

In conclusion, ambulatory blood pressure is a long‐term predictor of diastolic LV function outperforming distant but not concurrent conventional blood pressure. Masked and sustained hypertension carry equal risk for deterioration of diastolic LV function. The take‐home message of our current study is that multiple measurements of blood pressure outside the medical environment are superior to fewer measurements by observers to screen for diastolic LV dysfunction and that ambulatory monitoring, as already proposed more than a decade ago by Thomas Pickering[39](#jah32924-bib-0039){ref-type="ref"} and as reiterated in contemporary guidelines,[11](#jah32924-bib-0011){ref-type="ref"}, [12](#jah32924-bib-0012){ref-type="ref"}, [13](#jah32924-bib-0013){ref-type="ref"}, [14](#jah32924-bib-0014){ref-type="ref"} is the state‐of‐the‐art technique for assessing blood pressure in clinical practice and research.
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